Patents by Inventor Enej Kuscer

Enej Kuscer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230348506
    Abstract: The present disclosure relates to compounds of Formulae (I) or (II): and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.
    Type: Application
    Filed: November 25, 2020
    Publication date: November 2, 2023
    Inventors: Arthur George TAVERAS, Enej KUSCER, Angelina Roberta SEKIRNIK
  • Publication number: 20230107216
    Abstract: The present disclosure relates to compounds of Formula (I), (II), or (II?): (I), (II), (II?), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.
    Type: Application
    Filed: December 2, 2019
    Publication date: April 6, 2023
    Inventors: Arthur George TAVERAS, Enej KUSCER, Angelina Roberta SEKIRNIK, Dharini SHAH, Mercedes VALLS SERĂ“N
  • Publication number: 20230093594
    Abstract: The present disclosure relates to compounds of Formula (I) or (II): (Formulae (I), (II)), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.
    Type: Application
    Filed: March 27, 2020
    Publication date: March 23, 2023
    Inventors: Arthur George Taveras, Angelina Roberta Sekirnik, Enej Kuscer
  • Publication number: 20230072313
    Abstract: The present disclosure relates to compounds of Formula (P) or (II?-0): (Formulae (I?), (II?-0)), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.
    Type: Application
    Filed: December 2, 2019
    Publication date: March 9, 2023
    Inventors: Arthur George TAVERAS, Enej KUSCER, Angelina Roberta SEKIRNIK, Dharini SHAH, Mercedes VALLS SERON
  • Patent number: 8980585
    Abstract: Genetically modified strains of Streptomyces tsukubaensis (S. tsukubaensis) can be used for an improved fermentation process for the preparation of tacrolimus or a salt or derivative thereof by cultivation of these genetically modified strains. Novel genes allowing biosynthesis of allylmalonyl-CoA can be used for polyketide production with allylmalonyl extender unit.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: March 17, 2015
    Assignee: Lek Pharmaceuticals D.D.
    Inventors: Hrvoje Petkovic, Enej Kuscer, Stefan Fujs, Gregor Kopitar, Peter Mrak, Gregor Kosec
  • Publication number: 20120295316
    Abstract: Genetically modified strains of Streptomyces tsukubaensis (S. tsukubaensis) can be used for an improved fermentation process for the preparation of tacrolimus or a salt or derivative thereof by cultivation of these genetically modified strains. Novel genes allowing biosynthesis of allylmalonyl-CoA can be used for polyketide production with allylmalonyl extender unit.
    Type: Application
    Filed: July 9, 2010
    Publication date: November 22, 2012
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Hrvoje Petkovic, Enej Kuscer, Stefan Fujs, Gregor Kopitar, Peter Mrak, Gregor Kosec